<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Medical Developments International — News on 6ix</title>
    <link>https://6ix.com/company/medical-developments-international</link>
    <description>Latest news and press releases for Medical Developments International on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 24 Apr 2026 03:19:17 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/medical-developments-international" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836672f78dffbe2df15e3c5.webp</url>
      <title>Medical Developments International</title>
      <link>https://6ix.com/company/medical-developments-international</link>
    </image>
    <item>
      <title>Appendix 4C and Quarterly Activity Report 31 March 2026</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-march-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-march-2026</guid>
      <pubDate>Fri, 24 Apr 2026 03:19:17 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activity Report 31 March 2026</description>
    </item>
    <item>
      <title>FY26 Half Year Presentation</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy26-half-year-presentation</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy26-half-year-presentation</guid>
      <pubDate>Thu, 19 Feb 2026 03:15:10 GMT</pubDate>
      <description>FY26 Half Year Presentation</description>
    </item>
    <item>
      <title>FY26 Half Year Announcement</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy26-half-year-announcement</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy26-half-year-announcement</guid>
      <pubDate>Thu, 19 Feb 2026 03:15:10 GMT</pubDate>
      <description>FY26 Half Year Announcement</description>
    </item>
    <item>
      <title>FY26 Half Year Report (including Appendix 4D)</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy26-half-year-report-including-appendix-4d</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy26-half-year-report-including-appendix-4d</guid>
      <pubDate>Thu, 19 Feb 2026 03:14:18 GMT</pubDate>
      <description>FY26 Half Year Report (including Appendix 4D)</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activity Report 31 December 2025</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-december-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-december-2025</guid>
      <pubDate>Fri, 30 Jan 2026 02:42:30 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activity Report 31 December 2025</description>
    </item>
    <item>
      <title>Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO</title>
      <link>https://6ix.com/company/medical-developments-international/news/vaxxas-appoints-former-merck-global-vaccines-president-david-peacock-as-ceo</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/vaxxas-appoints-former-merck-global-vaccines-president-david-peacock-as-ceo</guid>
      <pubDate>Wed, 07 Jan 2026 13:01:00 GMT</pubDate>
      <description>Vaxxas HD-MAP Self Administration Vaxxas HD-MAP Self Administration Vaxxas CEO David Peacock Vaxxas CEO David Peacock Vaxxas HD-MAP Vaxxas HD-MAP BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive Officer to lead the commercialisation of the Company’s proprietary high‑density microarray patch (HD‑MAP) vaccination technology. Mr Peacock brings more than</description>
    </item>
    <item>
      <title>Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market</title>
      <link>https://6ix.com/company/medical-developments-international/news/vaxxas-appoints-veteran-vaccine-leader-to-board-as-company-advances-needle-free-vaccine-patch-towards-market</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/vaxxas-appoints-veteran-vaccine-leader-to-board-as-company-advances-needle-free-vaccine-patch-towards-market</guid>
      <pubDate>Mon, 10 Nov 2025 13:00:00 GMT</pubDate>
      <description>Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global use;SPRIM Global Investment’s Co-Founder and Managing Partner, Mr Michael Shleifer appointed Board Observer following recent ~$90 million financing. BRISBANE, Australia and CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology company Vaxxas Pty Ltd, today announced the appointment of Mr Brent MacGregor as Independent Non-Executive Dir</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activity Report 30 September2025</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-30-september2025</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-30-september2025</guid>
      <pubDate>Fri, 10 Oct 2025 02:25:14 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activity Report 30 September2025</description>
    </item>
    <item>
      <title>FY25 Full Year Results</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy25-full-year-results-5</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy25-full-year-results-5</guid>
      <pubDate>Thu, 21 Aug 2025 03:17:34 GMT</pubDate>
      <description>FY25 Full Year Results</description>
    </item>
    <item>
      <title>MVP Announces FY25 Full Year Results</title>
      <link>https://6ix.com/company/medical-developments-international/news/mvp-announces-fy25-full-year-results</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/mvp-announces-fy25-full-year-results</guid>
      <pubDate>Thu, 21 Aug 2025 03:17:32 GMT</pubDate>
      <description>MVP Announces FY25 Full Year Results</description>
    </item>
    <item>
      <title>FY25 Full Year Results Investor Presentation</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy25-full-year-results-investor-presentation-5</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy25-full-year-results-investor-presentation-5</guid>
      <pubDate>Thu, 21 Aug 2025 03:16:21 GMT</pubDate>
      <description>FY25 Full Year Results Investor Presentation</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activity Report - 30 June 2025</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-30-june-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-30-june-2025</guid>
      <pubDate>Thu, 31 Jul 2025 04:24:13 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activity Report - 30 June 2025</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activity Report - 31 March 2025</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-march-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-march-2025</guid>
      <pubDate>Tue, 29 Apr 2025 03:40:10 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activity Report - 31 March 2025</description>
    </item>
    <item>
      <title>FY25 Half Year Presentation</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy25-half-year-presentation</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy25-half-year-presentation</guid>
      <pubDate>Thu, 20 Feb 2025 02:42:37 GMT</pubDate>
      <description>FY25 Half Year Presentation</description>
    </item>
    <item>
      <title>FY25 Half Year Report (including Appendix 4D)</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy25-half-year-report-including-appendix-4d</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy25-half-year-report-including-appendix-4d</guid>
      <pubDate>Thu, 20 Feb 2025 02:42:37 GMT</pubDate>
      <description>FY25 Half Year Report (including Appendix 4D)</description>
    </item>
    <item>
      <title>FY25 Half Year Announcement</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy25-half-year-announcement</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy25-half-year-announcement</guid>
      <pubDate>Thu, 20 Feb 2025 02:42:35 GMT</pubDate>
      <description>FY25 Half Year Announcement</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activity Report -31 December 2024</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-december-2024</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-31-december-2024</guid>
      <pubDate>Fri, 31 Jan 2025 02:39:40 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activity Report -31 December 2024</description>
    </item>
    <item>
      <title>Appendix 4C &amp; Quarterly Activity Report - 30 September 2024</title>
      <link>https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-30-september-2024</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/appendix-4c-and-quarterly-activity-report-30-september-2024</guid>
      <pubDate>Tue, 22 Oct 2024 06:24:13 GMT</pubDate>
      <description>Appendix 4C &amp; Quarterly Activity Report - 30 September 2024</description>
    </item>
    <item>
      <title>FY24 Full Year Results Investor Presentation</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy24-full-year-results-investor-presentation-4</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy24-full-year-results-investor-presentation-4</guid>
      <pubDate>Mon, 26 Aug 2024 02:56:08 GMT</pubDate>
      <description>FY24 Full Year Results Investor Presentation</description>
    </item>
    <item>
      <title>FY24 Full Year Results</title>
      <link>https://6ix.com/company/medical-developments-international/news/fy24-full-year-results-5</link>
      <guid isPermaLink="true">https://6ix.com/company/medical-developments-international/news/fy24-full-year-results-5</guid>
      <pubDate>Mon, 26 Aug 2024 02:53:25 GMT</pubDate>
      <description>FY24 Full Year Results</description>
    </item>
  </channel>
</rss>